NKX2-1 (NK2 homeobox 1) is a critical transcription factor that functions as a lineage-specific regulator with diverse roles in development and disease. In normal physiology, NKX2-1 serves as a master regulator of thyroid differentiation, binding and activating promoters of thyroid-specific genes including thyroglobulin, thyroperoxidase, and thyrotropin receptor 1. Mechanistically, NKX2-1 acts as a pioneer transcription factor that binds gene promoters and interacts with other transcription factors through chr14 looping to regulate gene expression 2. The protein demonstrates dosage-dependent regulation, with amplification events controlling its oncogenic functions through super-enhancer targeting 3. NKX2-1 plays crucial roles in multiple disease contexts. In congenital hypothyroidism, heterozygous mutations in NKX2-1 cause thyroid dysgenesis 1, while mutations also lead to benign hereditary chorea, representing a key gene in this movement disorder syndrome 4. In cancer, NKX2-1 functions as both a tumor suppressor and oncogene depending on context. In lung adenocarcinoma, NKX2-1 suppression promotes tumor progression by activating neutrophil recruitment through CXCLs/CXCR2 signaling 5, while also driving metabolic rewiring through serine/glycine synthesis addiction 6. Additionally, NKX2-1 drives neuroendocrine transdifferentiation in prostate cancer through epigenetic remodeling 2 and cooperates with circular RNA circRMST in neuroendocrine differentiation 7.